Showing results (1-10 of 247) with videos related to
Sort By:
Pageof 25
Cold Spring Harbor Perspectives in Biology|December 5, 2012
Oncogenes in cell survival and cell deathJake Shortt, Ricky W JohnstoneCurrent Opinion in Hematology|May 10, 2014
Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphomaMichaela Waibel, Gareth Gregory, Jake Shortt, et al.Nature Reviews. Cancer|February 24, 2017
A chemical probe toolbox for dissecting the cancer epigenomeJake Shortt, Christopher J Ott, Ricky W Johnstone, et al.Haematologica|December 30, 2020
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myelomaMatteo Costacurta, Stephin J Vervoort, Simon J Hogg, et al.Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.Molecular Cell|November 7, 2002
Deamidation of Bcl-X(L): a new twist in a genotoxic murder mysteryRicky W JohnstoneIdrugs : the Investigational Drugs Journal|July 10, 2004
Suberanilohydroxamic Acid. Aton PharmaRicky W JohnstoneNature Reviews. Drug Discovery|July 18, 2002
Histone-deacetylase inhibitors: novel drugs for the treatment of cancerRicky W JohnstoneBlood|March 28, 2012
Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacyMarta Chesi, Geoffrey M Matthews, Victoria M Garbitt, et al.Cold Spring Harbor Protocols|December 10, 2016
In the Midst of Life-Cell Death: What Is It, What Is It Good for, and How to Study ItJohn Silke, Ricky W JohnstonePageof 25